APA (7th ed.) Citation

Zhang, H., Bu, C., Peng, Z., Li, G., Zhou, Z., Ding, W., . . . Li, C. (2022). Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: The multi-center efficacy and safety interim analysis. Leukemia, 36(11), 2596-2604. https://doi.org/10.1038/s41375-022-01703-0

Chicago Style (17th ed.) Citation

Zhang, Hui, et al. "Characteristics of Anti-CLL1 Based CAR-T Therapy for Children with Relapsed or Refractory Acute Myeloid Leukemia: The Multi-center Efficacy and Safety Interim Analysis." Leukemia 36, no. 11 (2022): 2596-2604. https://doi.org/10.1038/s41375-022-01703-0.

MLA (9th ed.) Citation

Zhang, Hui, et al. "Characteristics of Anti-CLL1 Based CAR-T Therapy for Children with Relapsed or Refractory Acute Myeloid Leukemia: The Multi-center Efficacy and Safety Interim Analysis." Leukemia, vol. 36, no. 11, 2022, pp. 2596-2604, https://doi.org/10.1038/s41375-022-01703-0.